Signum Life Science ApS: Financial statements 2022
CVR: 36559241
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -183,840 and a net result of DKK -11,313,396 compared with DKK 1,317,024 the year before. Equity in the 2022 report amounted to DKK 115,832,402. The solvency ratio was 86.8%. The company had 36 employees in the financial year.
- Gross Profit
- DKK -183,840
- Profit/Loss
- DKK -11,313,396
- Equity
- DKK 115,832,402
- Total Assets
- DKK 133,491,497
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -184K | -11.3M | 115.8M | 36 |
| 2021 | - | 7.6M | 1.3M | 128.5M | 34 |
| 2020 | - | 8.1M | 1M | 128.2M | 32 |
| 2019 | - | 10.5M | 3.8M | 129.2M | 28 |
| 2018 | - | 12M | 4.1M | 127.5M | 21 |
Official annual report
Keep an eye on Signum Life Science ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Signum Life Science ApS has published its annual report for 2021. Gross profit came to DKK 7,602,418, and the net result was DKK 1,317,024.
As of March 1, 2022, Jonas Emil Steenvinkel has joined the board of directors of Signum Life Science ApS.
As of March 1, 2022, Allan Karne Levisen has left the board of directors of Signum Life Science ApS.
As of February 28, 2022, Jonas Emil Steenvinkel has left the board of directors of Signum Life Science ApS.
About Signum Life Science ApS
Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.
